News Search Results
Jan 07, 2026, 08:31 ET TheWell Bioscience and PeptiGrowth Enter into Marketing Collaboration Agreement to Advance Next-Generation Cell Culture Solutions
MONMOUTH JUNCTION, N.J. and TOKYO, Jan. 7, 2026 /PRNewswire/ -- TheWell Bioscience Inc., a biotechnology company pioneering next-generation animal-free biofunctional hydrogels, and PeptiGrowth Inc., a leader in innovative synthetic peptide growth
More news about: TheWell Bioscience
Jan 07, 2026, 08:30 ET Navigating the Animal Rule in Drug Development with Modeling & Simulation, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Jan 07, 2026, 08:30 ET Bridging Bench to Bedside: De‑Risking Biotherapeutic Administration via CDMO‑Led Clinical‑Mimic and In‑Use Testing Strategies, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Jan 07, 2026, 08:30 ET The Power of Less: Winning with Asset-Light Manufacturing, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Jan 07, 2026, 08:05 ET Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
Calif., Jan. 7, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company
More news about: Rigel Pharmaceuticals, Inc.
Jan 07, 2026, 08:00 ET STRM.BIO Raises $8 Million in Series Seed 2 Financing to Advance Non-Viral Gene Delivery Platform for In Vivo Cell Engineering and Gene Therapy
STRM.BIO, a biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced $8 million in Series Seed 2 financing.
More news about: STRM.BIO
Jan 07, 2026, 07:33 ET GreenWay Herbal Products, LLC awarded a U.S. patent covering a 1-to-1 cannabidiol and cannabidiolic acid cannabinoid composition
business strategies. These include advancing pharmaceutical development efforts and pursuing strategic licensing partnerships with pharmaceutical, biotechnology and specialty health companies. The company is also evaluating opportunities where its patented cannabinoid composition could be combined with advanced
More news about: GreenWay Herbal Products, LLC
Jan 07, 2026, 07:33 ET Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval
investorsSAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing its proprietary Alluminox® platform-based photoimmunotherapy, today announced the closing of a
More news about: Rakuten Medical, Inc.
Jan 07, 2026, 07:30 ET Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States
TEL AVIV, Israel, Jan. 7, 2026 /PRNewswire/ -- Cytora Therapeutics Ltd. (Cytora), a clinical-stage biotechnology company based in Israel developing allogeneic, stem cell therapies; Made Scientific, Inc. (Made Scientific), a leading U.S.-based cell therapy contract
More news about: Made Scientific, Inc.; Cytora
Jan 07, 2026, 07:00 ET Nanoscope Therapeutics Granted New U.S. Patent Covering Its Proprietary Multi-Characteristic Opsin Platform for Vision Restoration
Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment
More news about: Nanoscope Therapeutics
Jan 07, 2026, 07:00 ET Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
Mediar Therapeutics, Inc., a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced an oversubscribed $76 million Series B financing co-led by
More news about: Mediar Therapeutics
Jan 07, 2026, 06:30 ET Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today highlighted its 2025 accomplishments
More news about: Immunic, Inc.
Jan 07, 2026, 03:30 ET AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board
Seasoned executive with extensive board experience across US and European biotechnology companiesBrings extensive operational, strategic and transactional expertise as AstronauTx advances its innovative pipeline targeting improvements in sleep architecture to
More news about: AstronauTx
Jan 07, 2026, 03:30 ET Lonza's Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next-Generation Bispecific ADCs
more at www.lonza.com.About Synaffix Synaffix B.V. is a biotechnology company that enables ADC product candidates using its clinical-stage, site-specific ADC technology platform based on GlycoConnect®, HydraSpace®
More news about: Synaffix
Jan 06, 2026, 19:00 ET HealthBiome Achieves Dual Regulatory Milestones: FDA NDI Acknowledgment and Korean MFDS Approval for HB05P Muscle Health Ingredient
interest.About HealthBiomeFounded in 2017 as a researcher-initiated startup from the Korea Research Institute of Bioscience and Biotechnology (KRIBB), HealthBiome Inc. is headquartered in Daejeon with a GMP manufacturing facility in Jeonju, South Korea. The company specializes in drug
More news about: HealthBiome, Inc.
Jan 06, 2026, 13:27 ET Aperture Therapeutics Announces First-In-Class MMP9 Antisense Oligonucleotide Program for ALS
SAN CARLOS, Calif., Jan. 6, 2026 /PRNewswire/ -- Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9
More news about: Aperture Therapeutics
Jan 06, 2026, 12:28 ET Ryan Douglas Named to Massachusetts Real Estate Bar Association's Board of Trustees
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Jan 06, 2026, 12:03 ET Espervita's EVT0185 Demonstrates Reversal of Metabolic Dysfunction and Liver Fibrosis in Cell Metabolism Publication
Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in
More news about: Espervita Therapeutics, Inc.
Jan 06, 2026, 12:00 ET National Student Leadership Conference and IEEE Partner to Advance Engineering & Technology Education for High School Students
NSLC's long-standing engineering and technology programs. Beginning Summer 2026, students enrolled in NSLC's Aerospace, Artificial Intelligence, Biotechnology, Cybersecurity, and Engineering programs will benefit from IEEE's global expertise in STEM education and curriculum design."We
More news about: National Student Leadership Conference
Jan 06, 2026, 11:18 ET How Does Community-Based Research Deliver Faster Results and Greater Access? Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Jan 06, 2026, 11:11 ET Enhancing Clinical Efficiency Through Master Protocol Trial Design, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Jan 06, 2026, 11:02 ET Merchant & Gould Opens Boston Office, Strengthening Its Depth and Breadth
broader support," said Timbers. "The firm's national platform, combined with our team's strengths, particularly in high-growth sectors such as biotechnology and software, creates a powerful synergy that benefits clients at every stage of the innovation lifecycle." Merchant has experienced rapid
More news about: Merchant & Gould
Jan 06, 2026, 11:00 ET Novoron Bioscience Awarded $2.5 Million NIH/NIA SBIR Grant to Accelerate Alzheimer's Drug Discovery with Human Brain Organoids
SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- Novoron Bioscience, a San Diego-based biotechnology company developing therapies for neurodegenerative diseases and neurological injury, has received a $2.5 million Small Business Innovation Research
More news about: Novoron Bioscience
Jan 06, 2026, 10:50 ET ANSI Launches U.S. Standards Strategy 2025: A Blueprint for American Competitiveness in the 21st Century
emerging technologies and investment in the full standards ecosystem."The technologies defining this decade—artificial intelligence, biotechnology, quantum computing—all depend on standards," said Dr. Laurie E. Locascio, ANSI president and CEO. "This strategy positions American companies and
More news about: American National Standards Institute
Jan 06, 2026, 10:44 ET NanoMosaic Appoints Dr. Anne Marie Morse as Chairwoman of Newly Formed Clinical Advisory Board
role in digital transformation initiatives at Geisinger. She has advised and served as a principal investigator across numerous pharmaceutical and biotechnology organizations and is a widely recognized educator and patient advocate.About NanoMosaic Inc.NanoMosaic is a next-generation
More news about: NanoMosaic